Tabalumab, also as atacicept, represents a unique therapeutic method for addressing autoimmune conditions. This recombinant monoclonal immunoglobulin primarily blocks B cell activating factor of BAFF, a crucial protein https://www.targetmol.com/compound/tabalumab